USPTO 2015–2025 USPTO PatentsView US Corporation

CytoSorbents, Inc.

USPTO PatentsView assignee record - 25 granted patents across 13 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01J (Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus).

RSS updates for this company

The verdict

According to USPTO PatentsView, Cytosorbents ranks #11,982 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 13 technology areas.

#11,982
of 49,997 US assignees by volume
Top 37%
by Innovation Score (39.9/100)
18.7
avg claims per patent
+88%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11982 · US Corporation #11,982 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 25 grants
  • UPPER-Q #11,982/49,997
  • PHOTO-FINISH Consort Medical
  • CPC-FOCUS B01J · 13 areas
  • INNOV-THIN 39.9/100
  • CLAIMS-RICH 18.7 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +88% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Consort Medical PLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cytosorbents’s 39.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Cytosorbents

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Cytosorbents's Innovation Score is 39.9/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Cytosorbents?

Each dot is one of Cytosorbents’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cytosorbents’s own 18.7 claims/patent is ABOVE the 17.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cytosorbents vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 24.924.92525.1 10152025 Granted patents (volume) Avg claims / patent Consort Medical PLC - 25, 20.4Consort MedicalContinental Advanced Lidar Solutions US, Inc. - 25, 21.04Continental Advan…Cree Fayetteville, Inc. - 25, 17.96Cree FayettevilleCroda, Inc. - 25, 17.32CrodaDana TM4 Inc. - 25, 17.28Dana TM4DEB IP Limited - 25, 13.52DEB IPDeep Render Ltd. - 25, 14.6Deep RenderDong-a University Research Foundation FOR Industry-academy Cooperation - 25, 11.08Dong-a University…CytoSorbents, Inc. - 25, 18.68Cytosorbents
Cytosorbents vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cytosorbents's grants concentrate

CytoSorbents, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 84% of grants classified under B01J (Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus). Peak complete grant year is 2021 (8 grants) versus a trough of 2 in 2017. By volume, Cytosorbents sits between Consort Medical PLC and Dong-a University Research Foundation FOR Industry-academy Cooperation.

Cytosorbents's three-year grant acceleration

CytoSorbents, Inc. shows 7 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at CytoSorbents's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows CytoSorbents holds 25 patents at rank #11,982, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near CytoSorbents

By rank, the assignees closest to #11,982 in granted patent volume.

Leaders in B01J (Chemical OR Physical Processes)

Other assignees with the most granted patents in CytoSorbents's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for CytoSorbents, neither rank-band nor same-CPC leaders (those blocks stay above). In B01J (Chemical OR Physical Processes), CytoSorbents ranks #214 of 2,755 assignees by patent count in that subclass.

Cytosorbents's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 2017201820192021202320242025 2
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
CytoSorbents, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 2 8.0%
2018 4 16.0%
2019 2 8.0%
2021 8 32.0%
2023 4 16.0%
2024 3 12.0%
2025partial year 2 8.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

CytoSorbents, Inc.'s patent record in context - here's where to go next.

  • CytoSorbents, Inc.'s lead technology class is B01J (Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus), 84% of its portfolio - see every assignee active in that class. Explore B01J
  • Ranked #11,982 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare CytoSorbents, Inc. against Consort Medical PLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 39.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.